Clinical Trial Exploring Psilocybin Therapy As A Treatment For Alcohol Use Disorder Achieves New Milestone
Clairvoyant Therapeutics announced that the first clinical trial participant in Finland enrolled in CLA-PSY-201 has received their first dose of the drug along with motivational enhancement therapy.
